ELOVL1-IN-3
ELOVL1-IN-3 (Compound 22) is a potent and orally active inhibitor of elongation of very long chain fatty acid 1 (ELOVL1) enzyme. ELOVL1-IN-3 serves as a useful tool for researching adrenoleukodystrophy (ALD) [1].
Product Specifications
CAS Number
2761063-99-2
UNSPSC
12352005
Target
ELOVL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/elovl1-in-3.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
[C@@H]1(C2=CC=CC=C2)OCCN(C3=CC(O[C@@H]4C[C@H](N5C=CC=N5)C4)=NC=N3)C1
Molecular Formula
C21H23N5O2
Molecular Weight
377.44
References & Citations
[1]Boyd MJ, et al. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1. J Med Chem. 2021;64 (24) :17777-17794.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PE Anti-Mouse FcεRIα Antibody[MAR-1]](https://cdn.genprice.uk/products/763/68dd1498061270361e7ce4af/imageurl/e-ab-f1188ud.webp)
